共 47 条
[1]
Buckley SA(2017)Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis Haematologica 102 865-73
[2]
Wood BL(2017)Measurable residual disease testing in acute myeloid leukaemia Leukemia 31 1482-90
[3]
Othus M(2021)2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party Blood 138 2753-67
[4]
Hourigan CS(2022)Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML Blood 139 1694-706
[5]
Ustun C(2010)Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 116 354-65
[6]
Linden MA(2017)Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Blood 129 424-47
[7]
Hourigan CS(2015)Acute myeloid leukemia ontogeny is defined by distinct somatic mutations Blood 125 1367-76
[8]
Gale RP(2022)Unified classification and risk-stratification in acute myeloid leukemia Nat Commun 13 4622-undefined
[9]
Gormley NJ(undefined)undefined undefined undefined undefined-undefined
[10]
Ossenkoppele GJ(undefined)undefined undefined undefined undefined-undefined